Albuminuria: all 142 studies
Page 2 of 2. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.
- Effect of NWT-03 on Blood PressureCompletedNCT02144740Not applicable
- Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney DiseaseStatus unknownNCT01918488Not applicable
- Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)TerminatedNCT01820078Phase 4
- Minocycline and Proteinuria in Diabetic NephropathyStatus unknownNCT01779089Not applicable
- Oral Paricalcitol in Renal Transplant Recipients for Reducing AlbuminuriaCompletedNCT01694160Phase 3
- Urinary Protein/Creatinine Ratio in a Single Urine Sample Versus 24-hour Proteinuria in Patients With Multiple MyelomaCompletedNCT01572857
- Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney DonationCompletedNCT01564966
- NOX-E36 in Patients With Type 2 Diabetes Mellitus and AlbuminuriaCompletedNCT01547897Phase 2
- Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRDCompletedNCT01459770Not applicable
- Effect of CSII and CGM on Progression of Late Diabetic ComplicationsCompletedNCT01454700Phase 4
- Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Transplant RecipientsCompletedNCT01436747Phase 3
- INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With MacroalbuminuriaCompletedNCT01398423Phase 2
- ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With MicroalbuminuriaCompletedNCT01375322Phase 4
- Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic PatientsStatus unknownNCT01316068Phase 4
- Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA PatientsCompletedNCT01195818Not applicable
- A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA NephropathyStatus unknownNCT01184599Phase 4
- The Effects of Bindarit in Diabetic NephropathyCompletedNCT01109212Phase 2
- Dietetic Intervention With Soluble Fiber in Type 2 Diabetes Mellitus (DM) Patients With Metabolic Syndrome (MS)CompletedNCT01071785Not applicable
- Correlation of Albuminuria With Arterial StiffnessCompletedNCT01041599
- Lowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover TrialCompletedNCT00974636Not applicable
- Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric PatientsTerminatedNCT00961207Phase 4
- Aldosterone in Diabetic NephropathyStatus unknownNCT00870402Phase 4
- Renal Insufficiency And Cardiovascular EventsCompletedNCT00715481
- Evaluation of Albuminuria HIV-Infected PatientsCompletedNCT00524992
- Spironolactone for Reducing Proteinuria in Diabetic NephropathyCompletedNCT00498537Not applicable
- Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With ProteinuriaCompletedNCT00493727Not applicable
- Prognostic Value of Cardiac and Renal Markers in Ischemic Stroke and Transient Ischemic AttackCompletedNCT00479518
- Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong KongTerminatedNCT00462202Phase 3
- Family Investigation of Nephropathy and Diabetes (F.I.N.D.)Active, not recruitingNCT00342927
- Eplerenone, ACE Inhibition and AlbuminuriaCompletedNCT00315016Phase 2
- Study of XL784 in Patients With Albuminuria Due to Diabetic NephropathyCompletedNCT00312780Phase 2
- Stress-relief Management for Treatment of Late Complications in Type 2 DiabetesStatus unknownNCT00263419Not applicable
- A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)CompletedNCT00235014Phase 4
- Aldosterone and Vascular Disease in Diabetes MellitusCompletedNCT00214825Not applicable
- Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and DiabetesTerminatedNCT00208221Phase 3
- Rationale and Design for Shiga Microalbuminuria Reduction TrialStatus unknownNCT00202618Phase 4
- Antialbuminuric Effects of Valsartan and LisinoprilTerminatedNCT00171600Phase 4
- Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.CompletedNCT00171561Phase 4
- A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood PressureCompletedNCT00171353Phase 4
- Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT00136773Phase 4
- Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney DiseaseCompletedNCT00118976Not applicable
- Irbesartan Versus Placebo in Combination With Ramipril for Treatment of AlbuminuriaCompletedNCT00095290Phase 4